SEK 222.0
(2.07%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 167.05 Million SEK | 5.55% |
2022 | 158.26 Million SEK | -2.74% |
2021 | 162.73 Million SEK | 47.57% |
2020 | 110.27 Million SEK | -12.88% |
2019 | 126.57 Million SEK | 13.41% |
2018 | 111.6 Million SEK | 22.79% |
2017 | 90.89 Million SEK | 22.55% |
2016 | 74.16 Million SEK | 13.29% |
2015 | 65.47 Million SEK | 52.92% |
2014 | 42.81 Million SEK | 65.01% |
2013 | 25.94 Million SEK | 25.33% |
2012 | 20.7 Million SEK | 16.3% |
2011 | 17.8 Million SEK | 27.62% |
2010 | 13.94 Million SEK | -5.61% |
2009 | 14.77 Million SEK | 10.41% |
2008 | 13.38 Million SEK | 325.97% |
2007 | 3.14 Million SEK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 49.11 Million SEK | 26.52% |
2024 Q1 | 38.81 Million SEK | -37.94% |
2024 Q3 | 38.39 Million SEK | -21.82% |
2023 Q4 | 62.55 Million SEK | 88.02% |
2023 Q2 | 46.19 Million SEK | 84.51% |
2023 FY | 167.05 Million SEK | 5.55% |
2023 Q1 | 25.03 Million SEK | -35.91% |
2023 Q3 | 33.26 Million SEK | -27.98% |
2022 Q4 | 39.06 Million SEK | 130.39% |
2022 FY | 158.26 Million SEK | -2.74% |
2022 Q1 | 49.81 Million SEK | -3.76% |
2022 Q2 | 52.42 Million SEK | 5.24% |
2022 Q3 | 16.95 Million SEK | -67.66% |
2021 Q2 | 38.68 Million SEK | 0.73% |
2021 Q4 | 51.76 Million SEK | 52.8% |
2021 Q1 | 38.4 Million SEK | 20.51% |
2021 FY | 162.73 Million SEK | 47.57% |
2021 Q3 | 33.87 Million SEK | -12.44% |
2020 Q1 | 33.51 Million SEK | 5.3% |
2020 Q4 | 31.87 Million SEK | 91.88% |
2020 FY | 110.27 Million SEK | -12.88% |
2020 Q3 | 16.61 Million SEK | -41.26% |
2020 Q2 | 28.27 Million SEK | -15.62% |
2019 Q2 | 37.93 Million SEK | 8.56% |
2019 Q3 | 21.87 Million SEK | -42.35% |
2019 Q1 | 34.94 Million SEK | -2.46% |
2019 FY | 126.57 Million SEK | 13.41% |
2019 Q4 | 31.82 Million SEK | 45.52% |
2018 Q1 | 23.18 Million SEK | 6.97% |
2018 FY | 111.6 Million SEK | 22.79% |
2018 Q4 | 35.82 Million SEK | 70.4% |
2018 Q3 | 21.02 Million SEK | -33.41% |
2018 Q2 | 31.57 Million SEK | 36.17% |
2017 Q4 | 21.67 Million SEK | 111.54% |
2017 Q1 | 34.34 Million SEK | 58.64% |
2017 Q2 | 24.62 Million SEK | -28.29% |
2017 Q3 | 10.24 Million SEK | -58.39% |
2017 FY | 90.89 Million SEK | 22.55% |
2016 Q4 | 21.64 Million SEK | 11.26% |
2016 FY | 74.16 Million SEK | 13.29% |
2016 Q2 | 19.14 Million SEK | 37.49% |
2016 Q3 | 19.45 Million SEK | 1.65% |
2016 Q1 | 13.92 Million SEK | -15.24% |
2015 Q4 | 16.42 Million SEK | -45.77% |
2015 Q3 | 30.29 Million SEK | 266.67% |
2015 Q2 | 8.26 Million SEK | -21.26% |
2015 FY | 65.47 Million SEK | 52.92% |
2015 Q1 | 10.49 Million SEK | -37.68% |
2014 Q1 | 7.5 Million SEK | -53.93% |
2014 FY | 42.81 Million SEK | 65.01% |
2014 Q4 | 16.83 Million SEK | 119.52% |
2014 Q3 | 7.66 Million SEK | -29.0% |
2014 Q2 | 10.8 Million SEK | 43.86% |
2013 Q2 | -357 Thousand SEK | 47.88% |
2013 Q3 | 10.69 Million SEK | 3094.68% |
2013 Q4 | 16.29 Million SEK | 52.44% |
2013 FY | 25.94 Million SEK | 25.33% |
2013 Q1 | -685 Thousand SEK | -110.05% |
2012 Q4 | 6.81 Million SEK | 71.12% |
2012 Q1 | 5.36 Million SEK | -22.83% |
2012 Q2 | 4.54 Million SEK | -15.19% |
2012 Q3 | 3.98 Million SEK | -12.41% |
2012 FY | 20.7 Million SEK | 16.3% |
2011 Q3 | 3.72 Million SEK | -19.87% |
2011 FY | 17.8 Million SEK | 27.62% |
2011 Q4 | 6.94 Million SEK | 86.37% |
2011 Q1 | 2.47 Million SEK | -72.77% |
2011 Q2 | 4.65 Million SEK | 87.84% |
2010 Q2 | 7.1 Million SEK | 260.13% |
2010 Q3 | 2.18 Million SEK | -69.22% |
2010 Q1 | -4.43 Million SEK | -159.31% |
2010 FY | 13.94 Million SEK | -5.61% |
2010 Q4 | 9.09 Million SEK | 315.78% |
2009 Q3 | 5.47 Million SEK | 470.59% |
2009 Q1 | 865 Thousand SEK | -87.74% |
2009 Q4 | 7.48 Million SEK | 36.71% |
2009 Q2 | 959 Thousand SEK | 10.87% |
2009 FY | 14.77 Million SEK | 10.41% |
2008 FY | 13.38 Million SEK | 325.97% |
2008 Q2 | 1.51 Million SEK | 0.0% |
2008 Q3 | 3.55 Million SEK | 133.93% |
2008 Q4 | 7.05 Million SEK | 98.7% |
2007 FY | 3.14 Million SEK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Acarix AB (publ) | -77.55 Million SEK | 315.402% |
ADDvise Group AB (publ) | 300.6 Million SEK | 44.427% |
ADDvise Group AB (publ) | 300.6 Million SEK | 44.427% |
Arcoma AB | 4.66 Million SEK | -3484.785% |
Bactiguard Holding AB (publ) | -131.93 Million SEK | 226.618% |
BICO Group AB (publ) | -618.3 Million SEK | 127.018% |
Boule Diagnostics AB (publ) | 39.27 Million SEK | -325.391% |
Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 353.365% |
Chordate Medical Holding AB (publ) | -29.57 Million SEK | 664.904% |
C-Rad AB (publ) | 44.24 Million SEK | -277.568% |
Duearity AB (publ) | -25.76 Million SEK | 748.414% |
Dignitana AB (publ) | -15.02 Million SEK | 1211.746% |
Episurf Medical AB (publ) | -94.8 Million SEK | 276.214% |
Getinge AB (publ) | 3.81 Billion SEK | 95.62% |
Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 344.063% |
Iconovo AB (publ) | -45.77 Million SEK | 464.925% |
Integrum AB (publ) | 6.51 Million SEK | -2465.146% |
Luxbright AB (publ) | -25.8 Million SEK | 747.373% |
Mentice AB (publ) | -679 Thousand SEK | 24702.504% |
OssDsign AB (publ) | -91.95 Million SEK | 281.664% |
Paxman AB (publ) | 12.61 Million SEK | -1223.805% |
Promimic AB (publ) | -9.11 Million SEK | 1932.101% |
Qlife Holding AB (publ) | -168.69 Million SEK | 199.024% |
SciBase Holding AB (publ) | -53.93 Million SEK | 409.704% |
ScandiDos AB (publ) | -13.48 Million SEK | 1338.975% |
Sectra AB (publ) | 518.49 Million SEK | 67.781% |
Sedana Medical AB (publ) | -65.54 Million SEK | 354.857% |
Senzime AB (publ) | -133.74 Million SEK | 224.903% |
SpectraCure AB (publ) | -21.35 Million SEK | 882.404% |
Stille AB | 44.95 Million SEK | -271.621% |
Vitrolife AB (publ) | -3.58 Billion SEK | 104.655% |
Xvivo Perfusion AB (publ) | 38.5 Million SEK | -333.831% |